Methods for assaying and measuring the efficacy of anti-nausea compounds
AssigneeAphios Corporation
InventorTrevor Percival Castor
Life of this patent
Estimating the term…
Abstract
This invention is for methods to quantify the inhibition of 5-HT induced contraction of human intestinal smooth muscle and an assay to measure the effects of compounds on nausea, irritable bowel syndrome and irritable bowel disease. This invention can be used to measure the incidence and severity of nausea, and can be used as quality control assay for developing and releasing medications for controlling nausea and emesis.
Claims14
A method or assay for measuring the effectiveness of test compounds for blocking or inhibiting 5-HT induced contraction of human intestinal smooth muscle cells (HISMC), comprising the steps of:
- (a) providing an in vitro sample of human intestinal smooth muscle cells (HISMC) in a cell culture growth medium for assay;
- (b) providing a sample test compound, with 5-HT3 antagonist properties, which inhibits contraction of human intestinal smooth muscle cells ((HISMC);
- (c) mixing or combining a selected amount of the test compound in a predetermined concentration with the in vitro sample of human intestinal smooth muscle cells ((HISMC);
- (d) measuring the contractile responsiveness of the HISMC sample to the test compound by measuring cell contraction vs time for a predetermined test period;
- (e) repeating the measuring using different concentrations of the test compound;
- and
- (f) determining, based on the measured data, the efficacy of the test compound to inhibit 5-HT induced contractions of the human intestinal smooth muscle cells (HISMC).
A kit for measuring the effectiveness of test compounds for blocking or inhibiting 5-HT induced contraction of human intestinal smooth muscle cells (HISMC), comprising the steps of:
- (g) providing an in vitro sample of human intestinal smooth muscle cells (HISMC) in a cell culture growth medium for assay;
- (h) providing a sample test compound, with 5-HT3 antagonist properties, which inhibits contraction of human intestinal smooth muscle cells ((HISMC);
- (i) mixing or combining a selected amount of the test compound in a predetermined concentration with the in vitro sample of human intestinal smooth muscle cells ((HISMC);
- (j) measuring the contractile responsiveness of the HISMC sample to the test compound by measuring cell contraction vs time for a predetermined test period;
- (k) repeating the measuring using different concentrations of the test compound;
- and
- (l) determining, based on the measured data, the efficacy of the test compound to inhibit 5-HT induced contractions of the human intestinal smooth muscle cells (HISMC).
Dependencies are inferred from the claim text.